Ipsen S.A.

IPN.PA | EURONEXT | 1 Followers
€105.80 +0.09% €0.10
Follow
Loading...

Fair Price

AHD706.03
Undervalued by 74.1%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Ipsen S.A. is a French pharmaceutical company headquartered in Paris. The company specializes in research, development, manufacturing, and distribution of drugs primarily focused on the treatment of cancer, neurological disorders, and other specialized therapeutic areas. Its portfolio includes drugs for the treatment of various types of cancer, as well as drugs for the treatment of neurological disorders, endocrine disorders, and gastroenterological diseases. Ipsen is known for its innovative research and development of drug products aimed at improving the lives of patients with serious illnesses. The company has a global presence and is considered one of the leading players in the field of specialized pharmaceutical care. Shares of Ipsen S.A. are publicly traded on the Paris Stock Exchange.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade